All Phage Therapy articles – Page 4
-
NewsScreening tool pinpoints phages with best potential as antibiotics
A new screening tool circumvents the difficulty of studying individual bacteriophage proteins and determining precisely how the virus wields these tools to kill their host bacteria.
-
NewsHarmful bacteria can elude predators when concealed in mixed colonies
Efforts to fight disease-causing bacteria by harnessing their natural predators could be undermined when multiple species occupy the same space, a new study has revealed.
-
NewsRegulatory pathway needs to be developed to make the most of phages: AMI
A regulatory pathway needs to be developed if the UK is to reap the benefits of bacteriophage therapy, Applied Microbiology International (AMI) has warned. France, Belgium and Poland are already developing programmes that take advantage of the potential of phage therapeutics, while bacteriophages - viruses that are capable of destroying ...
-
NewsNew leaf: AMI’s PhD studentship winner Naina Korotania talks trees and phages
Naina Korotania, winner of the Basil Jarvis PhD Studentship, which is awarded by Applied Microbiology International, is poised to embark on a PhD at the Univeristy of Birmingham, developing novel phage-based biopesticides to target cankers in four tree species.
-
News Vésale Bioscience receives €1.8M grant from European Innovation Council for PhageDiag project
Vésale Bioscience has announced it has received €1.8M in grants from the European Innovation Council (EIC) Accelerator Fund for its PhageDiag project, a phagogram using artificial intelligence that enables decentralized diagnostics and personalized treatment.
-
NewsAMI’s pitch on bacteriophages is winner of My Science Inquiry
Applied Microbiology International’s pitch to explore bacteriophages as an alternative to antimicrobial drugs has been selected by the Commons Science and Technology Committee as the winner of the My Science inquiry.
-
NewsViruses deploy CRISPR system to thwart bacterial defences
Researchers have shown that viruses engineered with a CRISPR-Cas system can thwart bacterial defenses and make selective changes to a targeted bacterium – even when other bacteria are in close proximity.
-
NewsAMI pitches Government to develop pathway to phage therapy
Applied Microbiology International is urging the UK Government to launch an inquiry to explore the regulatory barriers and opportunities for bacteriophage therapy in the UK, in order to explore their potential as an alternative or addition to conventional antimicrobial drugs.
- Previous Page
- Page1
- Page2
- Page3
- Page4
- Next Page
